Article - 09/07/2012 Career entry with a bachelor’s degree: a young graduate shares her experiences with us Opinions differ widely as to whether a bachelors degree is enough for a career in the business world. While business representatives tend to point out that bachelors graduates are most welcome in their company many students are of the opinion that a masters or doctorate degree is required. Julia Bottlang has a B. Sc. and was offered a job by Konstanz-based GATC Biotech after doing an internship there following her bachelors studies. Despite her…https://www.gesundheitsindustrie-bw.de/en/article/news/career-entry-with-a-bachelor-s-degree-a-young-graduate-shares-her-experiences-with-us
Article - 09/07/2012 Thirteen years into the Bologna Process The German Ministry of Education introduced the bachelor’s-master’s system with the goal of improving education and career opportunities as well as increasing the efficiency of academic education and research. Thirteen years after the signing of the Bologna Declaration in 1999, the transition to the bachelor’s-master’s system is far from complete. https://www.gesundheitsindustrie-bw.de/en/article/news/thirteen-years-into-the-bologna-process
Dossier - 09/07/2012 Bachelor’s and master’s under scrutiny – has the new study system stood the test? More practical relevance, shorter courses and courses that are compatible across Europe – when the decision to implement the bachelor’s and master’s system was made in Germany in 1999, there were high expectations and hopes for the positive changes to come. The question is, have these expectations been met? The time is now ripe for universities and companies to review the progress that has been made in achieving the goals of the Bologna…https://www.gesundheitsindustrie-bw.de/en/article/dossier/bachelor-s-and-master-s-under-scrutiny-has-the-new-study-system-stood-the-test
Press release - 06/07/2012 Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
Article - 02/07/2012 Together against liver failure Medicines that are usually effective in treating diseases can sometimes be associated with severe adverse effects. This can occur when the liver which normally metabolizes drugs and renders them harmless becomes overburdened and even collapses completely. Prof. Dr. Jens Timmer from the University of Freiburg and Prof. Dr. Ursula Klingmüller from the German Cancer Research Center DKFZ in Heidelberg have joined forces in a huge European research…https://www.gesundheitsindustrie-bw.de/en/article/news/together-against-liver-failure
Article - 02/07/2012 amcure GmbH is working on a new compound against pancreatic cancer amcure GmbH has identified a new compound with a new efficacy profile against pancreatic cancer. Animal experiments have shown promising results: the drug candidate successfully prevents tumour growth and destroys existing metastases. The company, which was spun out from the Karlsruhe Institute of Technology (KIT) in 2011, is now working on its first financing round and is looking for new investors. At the same time it is carefully planning its…https://www.gesundheitsindustrie-bw.de/en/article/news/amcure-gmbh-is-working-on-a-new-compound-against-pancreatic-cancer
Press release - 29/06/2012 Researchers establish brain tissue bank for research on degenerative diseases of the nervous system Professor Manuela Neumann has been appointed to a joint professorship at the German Center for Neurodegenerative Diseases DZNE and the University of Tübingen. In June she has been starting a the research group neuropathology at the DZNE site Tübingen and will also serve as the medical director of the neuropathology department at the Institute for Pathology and Neuropathology of the medical faculty and the university clinic. In her past research…https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-establish-brain-tissue-bank-for-research-on-degenerative-diseases-of-the-nervous-system
Press release - 27/06/2012 A Virtual Look at the Zebrafish Brain Scientists have long dreamed of being able to grasp the brain as a whole. A research team led by Junior Professor Dr. Olaf Ronneberger from the Department of Computer Science of the University of Freiburg and Prof. Dr. Wolfgang Driever developmental biologist at the Institute of Biology I has now taken a big step toward making this dream a reality. The Freiburg researchers developed microscopic imaging techniques and software for observing and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/a-virtual-look-at-the-zebrafish-brain
Article - 25/06/2012 CCCU biobank: indispensable for cancer researchers If everything goes according to plan, it takes no more than six minutes to prepare and place a tissue sample into the cryotank. Stored in liquid nitrogen at a temperature of minus 196°C, the biomaterial is ready to be used by the researchers from the Comprehensive Cancer Center at the Ulm University Hospital (CCCU). The biobank, which is currently being established at the CCCU, is funded by German Cancer Aid.https://www.gesundheitsindustrie-bw.de/en/article/news/cccu-biobank-indispensable-for-cancer-researchers
Article - 25/06/2012 New cooperative research centre on leukaemia established in Ulm The traditionally strong research into leukaemia at Ulm University is to be further strengthened by the German Research Foundation (DFG). The DFG will fund the new cooperative research centre (SFB) with 8.8 million euros for a period of four years, starting in July 2012. The SFB 1074 “Experimental Models and Clinical Translation in Leukaemias” aims to bring together basic research-oriented and clinical research. https://www.gesundheitsindustrie-bw.de/en/article/news/new-cooperative-research-centre-on-leukaemia-established-in-ulm
Article - 25/06/2012 The physiological importance of the Alzheimer protein While the role of the amyloid precursor protein (APP) in the development of amyloid plaques that are characteristic of Alzheimer’s disease is well known, the physiological role of this protein in the brain has remained elusive. However, the molecular biologist Professor Dr. Ulrike Müller from Heidelberg has now shown in mouse models that components of the APP gene family play a major role in synaptic plasticity, learning and memory. https://www.gesundheitsindustrie-bw.de/en/article/news/the-physiological-importance-of-the-alzheimer-protein
Article - 25/06/2012 A special biobank for neurological research Over the last few years, the Hertie Institute for Clinical Brain Research in Tübingen has established a comprehensive biobank for use in neurological research. The databank is available to scientists from research institutions and companies working on research into neurological diseases such as Parkinson’s and Alzheimer’s with the aim of finding new options for the diagnostics and therapy of such diseases.https://www.gesundheitsindustrie-bw.de/en/article/news/a-special-biobank-for-neurological-research-1
Article - 25/06/2012 Cannabidiol for the treatment of schizophrenic psychoses A hemp compound has been shown to increase the effect of the endogenous cannabinoid anandamide in the human brain, thus reducing the delusions associated with psychotic diseases. Studies carried out by Prof. Markus Leweke from the Central Institute of Mental Health in Mannheim involving patients with acute schizophrenic attacks show that the plant compound is better tolerated than currently approved antipsychotic drugs. https://www.gesundheitsindustrie-bw.de/en/article/news/cannabidiol-for-the-treatment-of-schizophrenic-psychoses
Article - 25/06/2012 From blood samples to granulate The issue of proper nutrition has become more centred on the individual there is growing recognition that nutrition needs to be adapted to an individuals specific way of life and requirements. In cooperation with its subsidiary the Institut für Angewandte Biochemie AG IABC Hepart AG a company based in the city of Kreuzlingen on Lake Constance develops dietary products food to help people lose weight and micronutrient preparations adapted to…https://www.gesundheitsindustrie-bw.de/en/article/news/from-blood-samples-to-granulate
Article - 18/06/2012 Medical ethicists: biobanks need harmonization rather than new laws There are statutory European provisions on biobanks that regulate biobank research in Europe to a certain extent. Christian Lenk, managing director of the Ethics Commission at Ulm University, calls for the harmonization of existing European regulations rather than the creation of new laws. https://www.gesundheitsindustrie-bw.de/en/article/news/medical-ethicists-biobanks-need-harmonization-rather-than-new-laws
Dossier - 18/06/2012 Biobanks – treasure chests for biomedical research Biobanking is still a very specialist subject. The Research Committee at the German Bundestag, the Office of Technology Assessment at the German Bundestag and the German Ethics Council are all interested in this biomedical research tool, which is both necessary and meaningful. However, opinions with regard to the ethical, legal and technical approach to biobanks differ. Since March 2012 it has become absolutely clear that Germany will not pass a…https://www.gesundheitsindustrie-bw.de/en/article/dossier/biobanks-treasure-chests-for-biomedical-research
Article - 18/06/2012 National biobanks for scientific research Biobanks are of key importance for biomedical research and for improving diagnostics and therapies involving new biomarkers. The German Federal Ministry of Education and Research is funding the National Biobank Initiative with a total of around 18 million euros. The initiative aims to standardize and combine the resources of five model locations, including the BioMaterialBank Heidelberg which integrates the tissue bank of the National Centre for…https://www.gesundheitsindustrie-bw.de/en/article/news/national-biobanks-for-scientific-research
Article - 18/06/2012 Not just a zoo for fish mutants The fish facilities of the Karlsruhe Institute of Technology KIT house around 9000 aquariums. Zebrafish with genetic defects are excellent model organisms for many biological studies. Prof. Dr. Uwe Strähle and his team at the Institute of Toxicology and Genetics ITG at KIT have been focusing for a long time on the development of the fish nervous system. The European Zebrafish Resource Center EZRC led by Prof. Strähle is currently being…https://www.gesundheitsindustrie-bw.de/en/article/news/not-just-a-zoo-for-fish-mutants
Article - 12/06/2012 Symbionts, parasites and a new hormone biosynthesis pathway Plants release strigolactones into the soil in order to attract friendly organisms and establish a symbiotic association with them. Unfortunately these plant hormones are also perceived by parasitic weeds. A team of researchers led by Salim Al-Babili from the University of Freiburg has now identified important steps in the biosynthesis of strigolactones as well as coming up with unexpected discoveries. Does the new knowledge enable researchers to…https://www.gesundheitsindustrie-bw.de/en/article/news/symbionts-parasites-and-a-new-hormone-biosynthesis-pathway
Article - 05/06/2012 Max Planck Director Izaurralde honored for groundbreaking research Professor Dr. Elisa Izaurralde has made important contributions to the field of RNA biology in recent years. The managing director of the Max Planck Institute for Developmental Biology in Tübingen explores the complex mechanisms of cellular gene regulation. For her work on mRNA regulation she has now been honored with the prestigious Ernst Jung Prize for Medicine.https://www.gesundheitsindustrie-bw.de/en/article/news/max-planck-director-izaurralde-honored-for-groundbreaking-research
Press release - 05/06/2012 Engineered moss produces human hormone Erythropoietin (EPO) is a human protein hormone that is predominantly produced in kidneys. Scientists from the Chair of Plant Biotechnology of the University of Freiburg, Germany, around Dr. Eva Decker and Professor Ralf Reski and from the Freiburg-based biotech company greenovation have genetically engineered the moss Physcomitrella patens in such a way that it now produces recombinant human asialo-EPO in the moss bioreactor. The researchers…https://www.gesundheitsindustrie-bw.de/en/article/press-release/engineered-moss-produces-human-hormone
Press release - 04/06/2012 DFG establishes 20 new Collaborative Research Centres The support ranges from new therapies for multiple sclerosis via the heroic tradition in ancient time to functional microgels. Attached is a selection of research approaches in science in Baden-Württemberg.https://www.gesundheitsindustrie-bw.de/en/article/press-release/dfg-establishes-20-new-collaborative-research-centres
Press release - 01/06/2012 immatics wins 2012 TiE50 Award Immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that it has been named a 2012 TiE50 winner. These prestigious awards recognize entrepreneurship, innovation and management excellence within the life sciences, software, internet, mobile and energy sectors.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-wins-2012-tie50-award
Press release - 01/06/2012 DFG Europa-Preis awarded to winners of national "Jugend forscht" competition Four young researchers had two reasons to celebrate at this year's awards ceremony for Germany’s "Jugend forscht" competition in Erfurt. Not only did the young researchers place first in their respective fields, they were also awarded the Europa-Preis of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).https://www.gesundheitsindustrie-bw.de/en/article/press-release/dfg-europa-preis-awarded-to-winners-of-national-jugend-forscht-competition
Press release - 01/06/2012 Locating ground zero Like emergency workers rushing to a disaster scene, cells called microglia speed to places where the brain has been injured, to contain the damage by ‘eating up’ any cellular debris and dead or dying neurons. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now discovered exactly how microglia detect the site of injury, thanks to a relay of molecular signals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/locating-ground-zero